Harvard Medical School 43rd Annual Intensive Review of Internal Medicine 2020 (Videos+PDFs)

50 $

Category: Internal Medicine Videos

Description

Introduction

Comments

Harvard Medical School 43rd Annual Intensive Review of Internal Medicine 2020 (Videos+PDFs)

Product Details

Oakstone Price: $1195.
Format: 171 Video Files (.mp4 format) + 2 PDF files.
File Size: 60.5 GB.

Harvard Medical School 43rd Annual Intensive Review of Internal Medicine 2020

Harvard Medical School and Brigham and Women’s Hospital Board Review

Convenient and Comprehensive

Staying on top of a seemingly endless number of internal medicine updates is made easier with the 43rd Annual Intensive Review of Internal Medicine. This online CME program includes 171 lectures across more than a dozen major topic areas, and features Harvard Medical School’s most distinguished faculty as they discuss the latest updates, best practices, and guidance for:

Exercising newer options for diagnosis
Treatment and care management strategies to optimize patient outcomes
Avoiding medical mistakes
Improved approaches to common and complex clinical challenges
Navigating screening controversies

Expand Your Skills

Available online or via USB, the 43rd Annual Intensive Review of Internal Medicine provides a maximum of 97.50 AMA PRA Category 1 Credits ™ and 97.50 ABIM MOC points. Get access to unbiased, evidence-based content and case-based reviews so you can prep for your board review, certification or recertification exams while discovering how to incorporate the latest guidelines into your daily practice.

Accreditation

The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Harvard Medical School designates this enduring material for a maximum of 97.50 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Original Release: September 15, 2020

Termination Date: January 31, 2023 (Please note that AMA PRA Category 1 Credits ™ will no longer be issued for the activity after this date)

Estimated Time to Complete the Activity: 97.50 hours

CME credit is awarded upon successful completion of a course evaluation and post-test.

Risk Management Credit

This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 2.25 credits of Risk Management Study. This includes:

.50 Credits of Opioid Education and Pain Management Training

.50 Credits of End-of-Life Care Studies

Please check your individual state licensing board requirements before claiming these credits.

ABIM MEDICAL KNOWLEDGE MOC POINTS

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 97.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

On the course evaluation page please indicate “Yes” when asked if you would like to receive ABIM MOC points for your participation in this enduring activity. You will then be required to provide your ABIM ID # and your Date of Birth. Points earned will equal the amount of AMA PRA Category 1 Credits ™ claimed.

HMS will upload the participant data, including the points earned, directly to the ABIM so that it will appear on the ABIM diplomates transcript. These points will not appear on your certificate provided at the end of this enduring activity.

Disclosure Policy

Harvard Medical School (HMS) adheres to all ACCME Accreditation Criteria and Policies. It is HMS’s policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that HMS may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Disclosure information for all individuals in control of the content of the activity is located on the disclosure statement in the PDF and printed syllabus.

Learning Objectives

After viewing this program, participants will be better able to:

Apply current/recommended guidelines in clinical practice
Perform differential diagnosis of complex clinical presentations
Identify/integrate current therapeutic options for specific disorders, including end-of-life care
Review and interpret up-to-date literature relevant to clinical practice
Describe pathophysiology as it applies to management of clinical problems
Apply knowledge gained to the ABIM certification/recertification examinations

ACGME Competencies

This course is designed to meet one or more of the following Accreditation Council for Graduate Medical Education Competencies:

Patient Care and Procedural Skills
Medical Knowledge
Practice-Based Learning and Improvement

Target Audience

The target audience for the Intensive Review of Internal Medicine course is clinical and academic internists, pediatricians, and primary care physicians/trainees preparing for ABIM internal medicine certification/recertification examinations and/or seeking a comprehensive update in internal medicine and its subspecialties.

Topics/Speaker:

Nephrology

Acute Kidney Injury – David E. Leaf, MD, MMSc

Revisiting Electrolytes – Bradley M. Denker, MD

Chronic Kidney Disease – Ajay K. Singh, MBBS, FRCP (UK), MBA

Acid-Base Basics – Bradley M. Denker, MD

Proteinuria, Hematuria, and Glomerular Disease – Martina M. McGrath, MB BCh

Dialysis and Transplantation – J. Kevin Tucker, MD

Nephrology Q&A – Ajay K. Singh, MBBS, FRCP (UK), MBA, and J. Kevin Tucker, MD

Hypertension Cases – Ajay K. Singh, MBBS, FRCP (UK), MBA

Nephrology Board Review – Ajay K. Singh, MBBS, FRCP (UK), MBA

Nephrology: Take-Home Messages and Clinical Pearls – Ajay K. Singh, MBBS, FRCP (UK), MBA

Electrolyte and Acid-Base: Challenging Q&A – Part 1 – Bradley M. Denker, MD

Electrolyte and Acid-Base: Challenging Q&A – Part 2 – Bradley M. Denker, MD

Acute Kidney Injury in COVID-19 – Peter G. Czarnecki, MD

Hematology

Anemia – Maureen M. Achebe, MBBS

Hypercoagulable States and New Anticoagulants – Nathan T. Connell, MD, MPH

Hematology Cases: Common, Complex, Rare – Nancy Berliner, MD

Bleeding Disorders – Elisabeth M. Battinelli, MD, PhD

Hematology Q&A – Nancy Berliner, MD, Maureen M. Achebe, MBBS, Nathan T. Connell, MD, MPH, and Elisabeth M. Battinelli, MD, PhD

Board Review in Hematology – Aric D. Parnes, MD

Leukocytosis and Neutropenia – Nancy Berliner, MD

Hematology: Additional Clinical Pearls & Take Home Messages – Nancy Berliner, MD

Coagulopathy in the Era of COVID-19 – Jean M. Connors, MD

Gastroenterology

Chronic Liver Disease and Its Complications – Anna E. Rutherford, MD, MPH

Esophageal Disorders – Walter W. Chan, MD, MPH

Diarrhea – Benjamin N. Smith, MD

Acute and Chronic Pancreatitis – Julia Y. McNabb-Baltar, MD

Challenging Gastroenterology Cases – Joshua R. Korzenik

Gastroenterology Q&A – Muthoka L. Mutinga, MD, Joshua R. Korzenik, Walter W. Chan, MD, MPH, and Benjamin N. Smith, MD

Peptic Ulcer Disease – Molly L. Perencevich, MD

Inflammatory Bowel Disease – Sonia Friedman, MD

Hepatitis B and C – Kathleen Viveiros, MD

Gastroenterology: Take-Home Messages and Clinical Pearls – Kunal Jajoo, MD

Gastroenterology Board Review – Muthoka L. Mutinga, MD

Oncology

Oncology: Clinical Pearls – Wendy Y. Chen, MD

Prostate, Testicular, and Bladder Cancer – Mark M. Pomerantz, MD

Breast Cancer – Wendy Y. Chen, MD

Lung Cancer – David M. Jackman, MD

Lymphoma and Multiple Myeloma – Eric D. Jacobsen, MD

Oncology Q&A – Wendy Y. Chen, MD, Mark M. Pomerantz, MD, David M. Jackman, MD, and Eric D. Jacobsen, MD

Leukemia and Myelodysplastic Syndrome – Marlise R. Luskin, MD MSCE

Gastrointestinal Cancers – Anuj Patel, MD

Oncology: Take-Home Messages and Clinical Pearls – Wendy Y. Chen, MD

Board Review in Oncology – Amy C. Bessnow, MD

Cardiovascular Medicine

Cardiovascular Prevention – Samia Mora, MD

Acute Coronary Syndrome – Marc S. Sabatine, MD

Venous Thromboembolism – Samuel Z. Goldhaber,MD

Atrial Fibrillation and Common Supraventricular Tachycardias – Sunil Kapur, MD

Bradycardias, Syncope and Sudden Death – Usha B. Tedrow, MD, MS

Valvular Heart Disease – Brendan M. Everett, MD, MPH

Peripheral Artery Disease – Gregory Piazza, MD

Congestive Heart Failure – Anju Nohria, MD

Cardiomyopathies – Akshay S. Desai, MD, MPH

Adult Congenital Heart Disease – Anne Marie Valente, MD

Cardiovascular Medicine Q&A – Akshay S. Desai, MD, MPH, Anne Marie Valente, MD, and Anju Nohria, MD

2020 Cardiology Overview – Leonard S. Lilly, MD

Must-Not-Miss ECG Diagnoses – Part 1 – Dale S. Adler, MD

Must-Not-Miss ECG Diagnoses – Part 2 – Dale S. Adler, MD

Inflammation and Atherothrombosis: What Clinicians Need to Know – Paul M Ridker, MD

Cardiology: Take-Home Messages and Clinical Pearls – Akshay S. Desai, MD, MPH

Board Review in Cardiology – Garrick C. Stewart, MD

Cardiac Issues in COVID-19 Patients – Erin A. Bohula, MD

Infectious Disease

Infection in the Immunocompromised Host – Sarah P. Hammond, MD

Adult Immunization – Daniel A. Solomon, MD

Pneumonia and Other Respiratory Tract Infections – Michael Klompas, MD, MPH

Sexually Transmitted Diseases – Todd B. Ellerin, MD

Infectious Disease Q&A – James H. Maguire, MD, Sarah P. Hammond, MD, and Michael Klompas, MD, MPH

Challenging Infectious Disease Cases – James H. Maguire, MD

Tropical Medicine and Parasitology – James H. Maguire, MD

HIV Disease: An Overview – Jennifer A. Johnson, MD

Tuberculosis for the Non-ID Specialist – Gustavo E. Velasquez, MD, MPH

Infectious Disease: Take-Home Messages and Clinical Pearls – Sarah P. Hammond, MD

Infectious Disease Board Review – Todd B. Ellerin, MD

Global Epidemiology and Status/Clinical Overview, Diagnosis and Treatment of COVID-19 – Lindsey R. Baden, MD

Clinical Presentation and Treatment of COVID-19 – Paul E. Sax, MD

Women’s Health

Menopause – Heather Hirsch, MD, MS, NCMP

Medical Complications of Pregnancy – Ellen W. Seely, MD

Evaluation of the Patient with Menstrual Irregularities – Maria A. Yialamas, MD

Contraception: An Update – Kari P. Braaten, MD

Osteoporosis and Metabolic Bone Disease – Carolyn B. Becker, MD

Women’s Health Q&A – Kathryn M. Rexrode, MD, Caren G. Solomon, MD, Ellen W. Seely, MD, Heather Hirsch, MD, MS, NCMP, and Carolyn B. Becker, MD

Cervical Cancer – Statistics, Etiology, and Screening – Annekathryn Goodman, MD

Interpersonal Violence and Trauma Informed Care – Eve Rittenberg, MD

Women’s Health: Take-Home Messages and Clinical Pearls – Lillian S. Mahrokhian, MD

Women’s Health Board Review – Kathryn M. Rexrode, MD

Pulmonary Medicine

Interstitial Lung Disease – Hilary J. Goldberg, MD

COPD – Craig P. Hersh, MD

Sleep Apnea – Lawrence J. Epstein, MD

Asthma – Christopher H. Fanta, MD

Pleural Disease – Scott L. Schissel, MD, PhD

Cystic Lung Disease – Souheil Y. El-Chemaly, MD

Pulmonary Medicine Q&A – Christopher H. Fanta, MD, Souheil Y. El-Chemaly, MD, Craig P. Hersh, MD, Lawrence J. Epstein, MD, and Scott L. Schissel, MD, PhD

Challenging Pulmonary Cases – Part 1 – Elizabeth B. Gay, MD

Challenging Pulmonary Cases – Part 2 – Bradley M. Wertheim, MD

Pulmonary Function Testing – Scott L. Schissel, MD, PhD

Pulmonary Disease Overview – Christopher H. Fanta, MD

Pulmonary Medicine: Take-Home Messages and Clinical Pearls – Christopher H. Fanta, MD

Chest X-ray Interpretation for the Boards – Christopher H. Fanta, MD

Pulmonary Board Review – Christopher H. Fanta, MD

Granulomatous Lung Disease – Rachel K. Putman, MD

Evaluation of Unexplained Dyspnea – David M. Systrom, MD

Chronic Cough – Christopher H. Fanta, MD

Neurology

Stroke – Galen V. Henderson, MD

Headache – Carolyn A. Bernstein, MD

Seizure Disorders – Ellen J. Bubrick, MD

Women’s Neurology – M. Angela O’Neal, MD

Neurology Q&A – Galen V. Henderson, MD, Carolyn A. Bernstein, MD, Ellen J. Bubrick, MD, and M. Angela O’Neal, MD

Neurology: Additional Clinical Pearls – Galen V. Henderson, MD

Board Review in Neurology – M. Angela O’Neal, MD

Movement Disorders – Abby Olsen, MD

General Internal Medicine/Primary Care/Hospital Medicine

End of Life (including COVID-19) – Lisa S. Lehmann, MD, PhD

Addiction in Pain Management – Sarah E. Wakeman, MD, FASM

Update in Geriatrics 2020 and COVID-19 – Suzanne E. Salamon, MD

Hyperlipidemia – Jorge Plutzky, MD

Biostatistics Board Review – Julie E. Buring, ScD

Obesity – Caroline M. Apovian, MD

Morning Report 2020: Instructive Cases – Maria A. Yialamas, MD

Challenging General Internal Medicine Cases – Richard N. Mitchell, MD and Joel T. Katz, MD

General Internal Medicine, Primary Care, Hospital Medicine Q&A – Lori W. Tishler, MD, Lisa S. Lehmann, MD, PhD, Sarah E. Wakeman, MD, FASM, Julie E. Buring, ScD, and Caroline M. Apovian, MD